Home

vyrobit Spona Suri zucman rossi stefano caruso Surichinmoi polokoule Zvětšení

Deleting the β-catenin degradation domain in mouse hepatocytes drives  hepatocellular carcinoma or hepatoblastoma-like tumor growth - ScienceDirect
Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth - ScienceDirect

10 Asks to Improve Liver Cancer Care and Prevention - EASL-The Home of  Hepatology.
10 Asks to Improve Liver Cancer Care and Prevention - EASL-The Home of Hepatology.

Stefano Caruso (@Stecarus) / Twitter
Stefano Caruso (@Stecarus) / Twitter

BERENGERE OUINE | Institut Curie
BERENGERE OUINE | Institut Curie

Hepatitis B virus integrations promote local and distant oncogenic driver  alterations in hepatocellular carcinoma | Gut
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma | Gut

Stefano Caruso (@Stecarus) / Twitter
Stefano Caruso (@Stecarus) / Twitter

Our Research
Our Research

Cancers | Free Full-Text | The lncRNA H19-Derived MicroRNA-675 Promotes  Liver Necroptosis by Targeting FADD
Cancers | Free Full-Text | The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADD

Chronic Alcohol Use : Genetic Variations Provide Protection from Liver  Cancer | Université Paris Cité
Chronic Alcohol Use : Genetic Variations Provide Protection from Liver Cancer | Université Paris Cité

Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as  first-line treatment for metastatic clear-cell renal cell carcinoma  (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised,  phase 2 trial - UROONCO Kidney Cancer
Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial - UROONCO Kidney Cancer

Cancers | Free Full-Text | Sigma 1 Receptor is Overexpressed in  Hepatocellular Adenoma: Involvement of ERα and HNF1α
Cancers | Free Full-Text | Sigma 1 Receptor is Overexpressed in Hepatocellular Adenoma: Involvement of ERα and HNF1α

Stefano Caruso (@Stecarus) / Twitter
Stefano Caruso (@Stecarus) / Twitter

BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma  with fibrolamellar-like features and activated PKA
BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA

TGFβ-induced FOXS1 controls epithelial-mesenchymal transition and predicts  a poor prognosis in liver cancer - Archive ouverte HAL
TGFβ-induced FOXS1 controls epithelial-mesenchymal transition and predicts a poor prognosis in liver cancer - Archive ouverte HAL

The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting  FADD
The lncRNA H19-Derived MicroRNA-675 Promotes Liver Necroptosis by Targeting FADD

Germline and somatic DICER1 mutations in familial and sporadic liver tumors
Germline and somatic DICER1 mutations in familial and sporadic liver tumors

Functional genomics of solid tumors - FunGeST -
Functional genomics of solid tumors - FunGeST -

PPT - Disclosure PowerPoint Presentation, free download - ID:603758
PPT - Disclosure PowerPoint Presentation, free download - ID:603758

Jessica ZUCMAN-ROSSI | Professor (Full) | MD, PhD | Centre de Recherche des  Cordeliers | Research profile
Jessica ZUCMAN-ROSSI | Professor (Full) | MD, PhD | Centre de Recherche des Cordeliers | Research profile

Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy  Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect
Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response - ScienceDirect

Study Points Toward New Ways to Prevent Liver Cancer | Mirage News
Study Points Toward New Ways to Prevent Liver Cancer | Mirage News

Functional genomics of solid tumors - FunGeST -
Functional genomics of solid tumors - FunGeST -

Frontiers | The Role of Chronic Liver Diseases in the Emergence and  Recurrence of Hepatocellular Carcinoma: An Omics Perspective
Frontiers | The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective

Stefano Caruso (@Stecarus) / Twitter
Stefano Caruso (@Stecarus) / Twitter

Loop | Jessica Zucman-Rossi
Loop | Jessica Zucman-Rossi

JILL PILET | Institut Curie
JILL PILET | Institut Curie

Functional genomics of solid tumors - FunGeST -
Functional genomics of solid tumors - FunGeST -

The pro-oncogenic effect of the lncRNA H19 in the development of chronic  inflammation-mediated hepatocellular carcinoma | Request PDF
The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma | Request PDF